Viking Therapeutics, Inc.
Viking Therapeutics, Inc. (VKTX) Stock Overview
Explore Viking Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4B
P/E Ratio
-11.03
EPS (TTM)
$-3.19
ROE
-0.48%
VKTX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Viking Therapeutics, Inc. (VKTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 56.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.78.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.03 and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.